Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Length of Clinical Trials Averages 555 Days: JPMA
November 8, 2004
- Price Negotiations Proceeding More Quickly This Year: Kraft
November 8, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 8, 2004
- BULLETIN
November 8, 2004
- Korosho to Build Up Core Hospital Network to Collect ADR Reports
November 8, 2004
- Importance of Alliance Increases for Domestic Companies: OPIR Report
November 8, 2004
- PMDA to Fund Regional Clinical Trial Network Project
November 8, 2004
- Mediceo Group Plans to Strengthen Healthcare Division
November 8, 2004
- Pharmacists Have Responsibility to Be "Drug Pros": Seminar
November 8, 2004
- AnGes MG Expecting 1st Product Launch in 2006
November 8, 2004
- Alan Bootes to Step Down as President of Pfizer Japan
November 8, 2004
- BULLETIN
November 8, 2004
- WORLD NEWS IN BRIEF
November 8, 2004
- MEDICAL DEVICE NEWS IN BRIEF
November 8, 2004
- REGULATORY NEWS IN BRIEF
November 8, 2004
- DIAGNOSTIC NEWS IN BRIEF
November 8, 2004
- 17 Types of Advanced Medical Technology Approved
November 8, 2004
- OTC NEWS IN BRIEF
November 8, 2004
- Urgent Listing for Valixa Tab Approved
November 8, 2004
- Press Seminar
November 8, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…